Current Month 2010
Article Features
  Bone Drug Suppresses Wandering Tumor Cells in Breast Cancer Patients
Breast Cancer Metastasis Increases After Progestin Hormone Therapies
Broccoli Component Limits Breast Cancer Stem Cells
Cost Concerns May Prevent Many Cancer Survivors from Getting Medical Care
Detection of Breast Cancer in Screening Mammography has Improved Over Time
Gene Mutation Increases Thromboembolism Risk in Women Taking Tamoxifen
Genetic Differences May Influence Joint Pain Among Women Taking Lifesaving Breast Cancer Drugs
Genetic Polarity in Breast Tumor Growth
Key Mechanism Identified in Breast Cancer
Molecular Imaging Helps Predict Breast Cancer Survival
Nanosponge Drug Delivery System More Effective than Direct Injection
New Target May Inhibit Metastatic Breast Cancer
Olive Oil Enriched Diet Helps Breast Cancer Survivors Lose More Weight
Overcoming Resistance to One Group of Breast Cancer Drugs
Peaches, Plums Induce Deliciously Promising Death of Breast Cancer Cells
Prenatal Exposure to Endocrine-Disrupting Chemicals Linked to Breast Cancer
Psychological Intervention Provides Enduring Health Benefits for Women with Breast Cancer
Radiation after Mastectomy Improves Breast Cancer Survival
Researchers Discover Gene Mutation Linked to Lymphedema
Researchers Discover New Way to 'Rescue' Treatment Sensitivity of Breast Cancer Cells
Researchers Link Ovarian Hormone to Altering of Breast Stem Cells
Screening Mammograms in Younger Women Have Low Accuracy and Detect Few Cancers
Slight Changes in Two Key Genes Appear to Launch Breast Cancer Development
Specially Trained Nurse Practitioner Detects Same Breast Abnormalities as Surgeon
Study Evaluates Importance of Timeliness of Care in Breast Cancer Diagnosis and Treatment
Study Identifies One of the Mechanisms Behind Breast Cancer Metastasis
Study Raises New Concerns About Radiation and Breast Cancer
Subtyping Breast Cancer by Immunohistochemistry to Investigate Survival
Targeted Immunotherapy Shows Promise for Metastatic Breast Cancer
Use of Unproven Mammography Tool Soars with Medicare Coverage


Gene Mutation Increases Thromboembolism Risk in Women Taking Tamoxifen

Women taking tamoxifen for early-stage breast cancer who developed blood clots were more likely to carry a gene mutation for clotting than women taking tamoxifen who did not develop blood clots, according to a study published in The Journal of the National Cancer Institute.

Tamoxifen is a widely-used breast cancer treatment after surgery for pre and post menopausal patients with hormone receptor-positive breast cancer. One of the most serious complications of tamoxifen usage is the development of blood clots, or thromboembolic events (TEs). Previous studies have shown that use of tamoxifen increases the risk of TEs in healthy women twofold, and that in women aged 50 and above, it is associated with even greater risk. The genetic mutation Factor V Leiden (FVL) is the most common inherited clotting factor mutation and also causes increased thrombosis risk.

To determine if having the Factor V Leiden genetic mutation increases the risk of thromboembolisms among women taking tamoxifen, Judy E. Garber, M.D. of the Dana-Farber Cancer Institute, and colleagues at the National Cancer Institute's Cancer and Leukemia Group B (CALGB) looked at 412 women who received the drug as adjuvant treatment for stage I, II, or IIIA breast cancer, between January 1999 and April 2005. The women, whose median age was 64, included 141 patients who developed TEs and 271 who did not.

The researchers found that women who had experienced a thromboembolism while taking tamoxifen were nearly five times more likely to carry the FVL mutation compared with the women who did not develop a thromboembolism. This result differed from previous studies, which found no associated risk of TEs or an increased presence of FVLs among women at risk of breast cancer, but who did not actually have the disease.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon